| 000 | 02651nam a22003855i 4500 | ||
|---|---|---|---|
| 001 | 86369 | ||
| 003 | ES-MaUEC | ||
| 005 | 20240611040147.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 160923s2016 gw | s |||| 0|eng d | ||
| 020 | _a9783319469065 | ||
| 040 | _aES-MaUEC | ||
| 050 | 4 |
_aQR185.8.I56 _bL37 2016 EB |
|
| 082 | 0 | 4 | _a616.079 |
| 100 | 1 |
_aLasek, Witold _0Local _0http://id.loc.gov/authorities/names/n2017183280 _1http://viaf.org/viaf/102024087 _9100039 |
|
| 245 | 1 | 0 |
_aInterleukin 12: Antitumor Activity and Immunotherapeutic Potential in Oncology _cby Witold Lasek, Radoslaw Zagozdzon |
| 264 | 1 |
_aCham _bSpringer International Publishing _c2016 |
|
| 300 |
_a1 recurso en línea (VII, 75 páginas) _b6 ilustraciones |
||
| 336 |
_aTexto (visual) _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 490 | 0 |
_aSpringerBriefs in Immunology _x2194-2773 |
|
| 520 | _aThis book discusses the immunotherapeutic potential of Interleukin 12 in the context of clinical oncology, as well as antitumor effects confirmed in preclinical studies and clinical trials in cancer immunotherapy. Due to its ability to activate both innate (NK cells) and adaptive (cytotoxic T lymphocytes) immunities, Interleukin 12 (IL-12) has been regarded as a promising candidate for tumor immunotherapy. However, despite the encouraging results in animal models, only very modest antitumor effects have been confirmed in early clinical trials. Recently, several clinical studies have been initiated in which IL-12 was applied as an adjuvant in cancer vaccines, in gene therapy including locoregional injections of IL-12 plasmid, and in the form of tumor-targeting immunocytokines (IL-12 fused to monoclonal antibodies). | ||
| 650 | 7 |
_aInmunología _2embne _9138330 |
|
| 700 | 1 |
_aZagozdzon, Radoslaw _0Local _0http://id.loc.gov/authorities/names/n2017183279 _1http://viaf.org/viaf/5478149296284080670001 _9100040 |
|
| 710 | 2 |
_aSpringerLink (Online service) _0Local _0http://id.loc.gov/authorities/names/no2005046756 _1http://viaf.org/viaf/148105729 _9106996 |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-46906-5 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 901 | _ai9783319469065 | ||
| 907 |
_a.b12956478 _b10-10-17 _c21-11-16 |
||
| 942 |
_2lcc _cLE |
||
| 945 |
_aEBOOK EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11615527 _z30-06-17 |
||
| 988 | 0 | 0 | _aEBOOK, EBSPRINGER, GOBI_sep2018 |
| 988 | _aEbook_one2one | ||
| 998 |
_aSI _a_alco _a_vill _b10/2018 _cm _dz _ef _feng _ggw _h0 |
||
| 999 |
_c86369 _d86369 _x1 |
||